Stay updated on Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.

Latest updates to the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page
- Check3 days agoChange DetectedAdded a large batch of 2025-era Study Status entries with facility names and location details, and replaced granular location fields with standardized Facility name, Location, and Location countries.SummaryDifference100%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated to a new version, v2.16.12, with the previous version, v2.16.11, being removed. Additionally, the date has been changed from August 6, 2025, to August 13, 2025.SummaryDifference0.6%
- Check40 days agoChange DetectedThe web page has updated its version from v2.16.10 to v2.16.11, and the date has changed from July 28, 2025, to August 6, 2025.SummaryDifference1.0%
- Check47 days agoChange DetectedThe webpage has removed a service alert regarding planned maintenance and updated the revision date. Additionally, an earlier revision date has been deleted.SummaryDifference5%
- Check55 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.8%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.3%
Stay in the know with updates to Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.